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Summary
 
Specific pathways linking heterotrimeric G proteins and Fc
 
g
 
 receptors to the actin-based cyto-
skeleton are poorly understood. To test a requirement for Rho family members in cytoskeletal
events mediated by structurally diverse receptors in leukocytes, we transfected the full-length
human chemotactic peptide receptor in RAW 264.7 cells and examined cytoskeletal alterations
in response to the chemotactic peptide formyl-methionyl-leucyl-phenylalanine (FMLP), col-
ony stimulating factor–1 (CSF-1), IgG-coated particles, and phorbol 12-myristate 13-acetate
(PMA). Expression of Rac1 N17, Cdc42 N17, or the GAP domain of 
 
n
 
-chimaerin inhibited
cytoskeletal responses to FMLP and CSF-1, and blocked phagocytosis. Accumulation of F-actin–
rich “phagocytic cups” was partially inhibited by expression of Rac1 N17 or Cdc42 N17. In
contrast, PMA-induced ruffling was not inhibited by expression of Rac1 N17, but was blocked
by expression of Cdc42 N17, indicating that cytoskeletal inhibition by these constructs was
nonoverlapping. These results demonstrate differential requirements for Rho family GTPases
in leukocyte motility, and indicate that both Rac1 and Cdc42 are required for Fc
 
g
 
 receptor–
mediated phagocytosis and for membrane ruffling mediated by structurally distinct receptors in
macrophages.
 
M
 
embers of the Rho family of GTPases have been
implicated in cytoskeletal alterations mediated by
many agonists (for review see references 1 and 2). In partic-
ular, Rac1 has been shown to be required for membrane
ruffling induced by growth factors (3, 4). A role for Cdc42
has been demonstrated for the formation of filopodia (5), as
well as for phagocytosis of 
 
Salmonella
 
 in COS-1 cells (6).
Other roles, such as the formation of stress fibers, have
been proposed for RhoA (for review see reference 7), al-
though there are also reports of a requirement for this GTPase
in the invasion of 
 
Shigella
 
 in sessile cells (8, 9).
Leukocytes have long served as model systems for cell
motility. Among the best characterized model systems are
responses to the chemotactic peptide FMLP, the prototypic
G protein–linked receptor agonist, in human neutrophils,
and phagocytosis via Fc
 
g
 
Rs in macrophages. Studies in pri-
mary cells and transfected cell lines indicate a requirement
for a conserved immunoreceptor tyrosine activation motif
and Syk tyrosine kinase in phagocytic signaling (for review
see references 10 and 11). However, the identities of down-
stream effectors that lead to cytoskeletal alterations in re-
sponse to Fc
 
g
 
R ligation are unknown. The superficial re-
semblance of submembranous accumulations of F-actin that
accrue during phagocytosis (“phagocytic cups”) and mem-
brane ruffles mediated by growth factors suggests that one
or more Rho family GTPases are required for phagocytic
signaling in leukocytes, but this has not been reported. In
addition, a role for GTPases in motile events occurring in
human neutrophils has been difficult to test since these cells
are difficult to microinject, and there are no reports that
neutrophils are capable of expressing recombinant proteins.
For the FMLP receptor, the pathways coupling receptor-
activated G proteins to the actin-based cytoskeleton are
poorly understood.
We were interested in testing whether Rac1 or Cdc42
were required for the cytoskeletal alterations triggered by
diverse stimuli in a single cell type. A uniform requirement
for these GTPases would suggest that the signal transduc-
tion pathways that ensue upon receptor ligation converge
at a single point, the activation of the GTPase. On the other
hand, differential requirements for individual GTPases by
structurally diverse receptors would suggest that these pro-
teins have nonoverlapping functions. To test whether these
GTPases are required for leukocyte motility, we derived
stable clones of a leukocyte cell line that inducibly ex-
pressed epitope-tagged versions of GTPases defective in bind-
ing guanine nucleotides. We also expressed a GAP domain
that would be predicted to limit the cellular accumulation
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of GTP-bound, and hence active, forms of Rac and Cdc42.
We tested the ability of these cells to undergo membrane
ruffling and phagocytosis.
 
Materials and Methods
 
Cells and Reagents.
 
RAW 264.7 mouse macrophage cell line
(RAW)
 
1
 
 cells were obtained from the American Type Culture
Collection (Rockville, MD) and were maintained in RPMI me-
dium containing 10% FCS, 100 U/ml penicillin G, and 100 
 
m
 
g/ml
streptomycin. Anti-Myc antibody (clone 9E10) was a gift of James
Angelastro (Columbia University, New York). mAb C4 against
actin was a gift of James Lessard (University of Cincinnati, Cin-
cinnati, OH). Rabbit anti–sheep erythrocyte IgG was from Dia-
medix (Miami, FL). Rhodamine-phalloidin and formyl-Nle-Leu-
Phe-Nle-Tyr-Lys, a tetramethylrhodamine derivative, were from
Molecular Probes (Eugene, OR). FITC-conjugated anti–mouse
IgG and Cy5- and rhodamine-conjugated anti–rabbit IgG were from
Jackson ImmunoResearch (West Grove, PA). Hygromycin B and
G418 sulfate were from GIBCO BRL (Gaithersburg, MD). Mu-
rine CSF-1 was from PharMingen (San Diego, CA). Puromycin and
pertussis toxin were from Sigma Chemical Co. (St. Louis, MO).
 
Construction of Plasmids and Transfection of Cells.
 
All transfec-
tions were done using CaPO
 
4
 
 precipitation. To establish stable
RAW cell clones that expressed the Lac repressor protein, RAW
cells were transfected with p3
 
9
 
SS (Stratagene, La Jolla, CA) and
stable clones were isolated in the presence of 0.5 
 
m
 
g/ml hygro-
mycin B. Expression of the Lac repressor protein was verified by
indirect immunofluorescence. A single clone was selected and trans-
fected with the full-length human FMLP receptor (gift of Philip
Murphy, National Institutes of Health, Bethesda, MD) subcloned
into pApuro (reference 12; provided by Tomohiro Kurosaki, Kan-
sai Medical University, Noriguchi, Japan). Single clones were se-
lected in the presence of 5 
 
m
 
g/ml puromycin and expression was
verified using a rhodamine-derivatized chemotactic peptide, formyl-
Nle-Leu-Phe-Nle-Tyr-Lys, and fluorescence microscopy. A sin-
gle clone (RAW LacR/FMLPR.2) was used for further transfec-
tions with Myc-tagged Rho family GTPases subcloned into
pCMV3Rluc, a plasmid containing multiple copies of the Lac re-
pressor binding site (gift of Len Stephens, Babraham Institute,
London, UK). Myc-tagged human Rac1 N17 and Cdc42 N17
were constructed as described (13, 14). Myc-tagged Chimaerin-
GAP, containing residues 106–299 of 
 
n
 
-Chimaerin, was con-
structed using PCR techniques and inserted into pCMV3RLuc.
Myc-tagged 
 
n
 
-Chimaerin was provided by Roman Herrera (Parke-
Davis Pharmaceutical Research Division, Ann Arbor, MI). All
constructs were verified by DNA sequencing. After transfection
of RAW LacR/FMLPR.2 with pCMV3RLuc containing the in-
dicated constructs, single clones of cells were isolated in the pres-
ence of 1 mg/ml G418 using limiting dilution, and were screened
for expression of the Myc epitope after an overnight incubation
in 10 mM IPTG. 2 mM sodium butyrate and 50 
 
m
 
M zinc acetate
were routinely added to further enhance expression of the in-
duced proteins. Between 50 and 200 individual clones transfected
with each construct were screened for expression. Three to six
clones were selected for further analysis using the following crite-
ria: first, lack of significant basal (uninduced) expression. Depend-
ing on the clone, a small percentage of the adherent cell popula-
tion stained positive with anti-Myc mAb even when maintained
in the absence of IPTG. Although these cells appeared very
bright, they accounted for only a small percentage of the popula-
tion (
 
,
 
1%). Second, clones were selected for high levels of in-
duced expression, both in terms of the percentage of cells ex-
pressing the Myc epitope and the level of expression of individual
cells, as indicated by bright immunofluorescent staining using
anti-Myc mAb. Clones which demonstrated variable intensities of
staining with mAb anti-Myc were not analyzed further. Finally,
clones were selected for stability of expression (i.e., cells could be
maintained in culture for several months without losing inducible
expression of the Myc-tagged constructs).
 
Cell Stimulation, Immunofluorescence Microscopy, and Immunoblot-
ting.
 
10
 
5
 
 cells were plated on round glass coverslips in a 24-well
plate in complete medium containing 50 
 
m
 
M zinc acetate and
2 mM sodium butyrate, and in the presence or absence of 10 mM
IPTG. After an overnight induction period, adherent cells were
washed, serum-starved in RPMI for 1 h, and incubated at 37
 
8
 
C
for a further 10 min in a buffer containing 125 mM NaCl, 5 mM
KCl, 1 mM KH
 
2
 
PO
 
4
 
, 5 mM glucose, 10 mM NaHCO
 
3
 
, 1 mM
MgCl
 
2
 
, 1 mM CaCl
 
2
 
, and 20 mM Hepes, pH 7.4. Maximal ruf-
fling was induced by the addition of 100 nM FMLP for 1 min, 10
ng/ml CSF-1 for 5 min, or 100 nM PMA for 5 min before fixa-
tion.
For phagocytosis assays, 5 
 
3
 
 10
 
6
 
 sheep erythrocytes opsonized
with rabbit IgG (IgG-RBCs) were added to adherent cell cultures
for 30 min as previously described (15). To assess submembranous
accumulations of F-actin beneath attached IgG-RBCs (phago-
cytic cup formation), adherent cells were incubated with IgG-
RBCs for 30 min at 4
 
8
 
C to allow particle attachment and, after
washing with ice-cold buffer, cells were incubated for a further 5
min at 37
 
8
 
C before fixation.
Adherent cells were fixed in 3.7% formaldehyde and stained
for the presence of the Myc epitope with mAb 9E10, for F-actin
with 0.33 
 
m
 
M rhodamine-phalloidin, and for IgG-RBCs with anti–
rabbit IgG, when indicated. Immunofluorescence microscopy was
performed as previously described (16). For photomicroscopy,
the stained cells were imaged using a confocal scanning system
equipped with a Krypton-Argon laser (MRC 600; Bio-Rad Lab-
oratories, Hercules, CA). Stacked confocal Z sections were col-
lected. For quantitation of Myc expression, microspectrofluorometry
using an Axioplan fluorescence microscope (Carl Zeiss, Inc.,
Thornwood, NY) equipped with a photomultiplier tube was per-
formed as previously described (15). All fluorescence values were
corrected for cellular autofluorescence, which was negligible, and
fluorescence of stained untransfected controls not expressing the
Myc epitope, which was typically between 5 and 10% of the total
fluorescence signal. Immunoblotting was performed as previously
described (17).
 
Quantitation of Ruffling and Phagocytosis.
 
Ruffling was defined
by the presence of F-actin–rich submembranous folds using fluo-
rescence microscopy. The extent of ruffling of each cell was
scored using a scale of 0–2, where 0 indicates that no ruffles were
present, 1 indicates that ruffling was confined to one area of the
cell only (
 
,
 
25% of the cell’s circumference), and 2 indicates that
two or more discrete areas of the cell contained ruffles. The ruf-
fling index was recorded as the sum of the ruffling scores of 100
cells. For all agonists, the ruffling index of cells incubated in the
absence of IPTG was not significantly different than the ruffling
index of cells that were incubated with IPTG but did not express
the Myc epitope. A separate ruffling index was calculated for cells
expressing the Myc epitope (usually 20–60% of the total adherent
 
1
 
Abbreviations used in this paper
 
: Chimaerin-GAP, the GAP domain of
 
n
 
-chimaerin; IgG-RBCs, sheep erythrocytes opsonized with rabbit IgG;
IPTG, isopropyl 
 
b
 
-
 
d
 
-thiogalactopyranoside; RAW cells, RAW 264.7
mouse macrophage cell line. 
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cell population). At least five separate fields were analyzed for the
presence of the Myc epitope, and all cells expressing Myc were
analyzed for extent of ruffling. Ruffling assays were performed in
duplicate.
The phagocytosis index was measured by counting the number
of ingested erythrocytes per 100 RAW cells after a 30-min incu-
bation with IgG-RBCs. Ingested erythrocytes appeared as phase-
lucent vacuoles which also stained positive for the presence of rho-
damine anti–rabbit IgG (18). Phagocytosis assays were performed
in duplicate.
All experiments depict data obtained from single clones of the
indicated constructs; similar results were obtained for three to six
additional clones of each construct.
 
Results
 
Expression of the Human FMLP Receptor in RAW Cells Re-
sults in a Functionally Intact Cytoskeletal Response to FMLP.
 
Although specific macrophage subpopulations respond to the
chemotactic peptide, FMLP (19, 20), murine macrophage
cell lines lack this responsiveness. To attempt to reconsti-
tute functionally intact FMLP receptors in a murine mac-
rophage cell line, we transfected cDNAs encoding the full-
length human FMLP receptor in RAW cells and derived
several resultant stable clones. All clones expressed func-
tional FMLP receptors at their surfaces since they bound
rhodamine-tagged chemotactic peptide (results not shown).
In contrast to quiescent cells, which demonstrated rela-
tively few surface projections (Fig. 1 
 
a
 
), addition of 100 nM
FMLP resulted in the appearance of F-actin–rich membrane
ruffles in essentially 100% of the transfectants within 15 s of
stimulation. No ruffling was seen in untransfected cells in-
cubated with FMLP (results not shown). The ruffling re-
sponse in the transfectants peaked at 1 min (Fig. 1 
 
b
 
), and
had declined by 20 min (not shown). Membrane ruffles ap-
peared diffusely throughout the cell. The extent of ruffling
by FMLP, but not by CSF-1, was reduced to control levels
in the presence of pertussis toxin (Fig. 1 
 
d
 
), indicating that
cytoskeletal coupling by the transfected receptors was me-
diated by G
 
i
 
, or a structurally similar heterotrimeric G pro-
tein. These data suggest that RAW cells expressing the hu-
man FMLP receptor use signal transduction pathways that
are similar to those triggered by this serpentine receptor in
primary leukocytes.
In contrast, addition of CSF-1 induced membrane ruffles
in these cells, but the response was slower, peaking at 5
min, and the ruffles appeared in distinct patches (Fig. 1 
 
c
 
).
The ability of RAW cells to respond to CSF-1 by mem-
brane ruffling is reminiscent of similar responses in primary
mouse macrophages (21). Thus, RAW cell transfectants in-
cubated with two structurally disparate agonists, FMLP and
CSF-1, behave like primary macrophages and display mor-
phologically similar, but not identical, responses.
 
Expression of Dominant-negative Rho Family GTPases in
RAW Cell Transfectants.
 
To test a requirement for Rac1
and Cdc42 on membrane ruffling in RAW cells, we ex-
pressed inducible GTP binding–deficient versions of these
proteins in RAW cells and selected stable clones. As a com-
plementary approach, we also utilized the GAP domain of
 
n
 
-chimaerin (Chimaerin-GAP), previously shown to dis-
play GAP activity towards Rac1 and Cdc42 (22). Expres-
sion of Chimaerin-GAP would be expected to decrease the
accumulation of GTP-bound (active) forms of Rac1 and
Cdc42. We used a RAW cell clone (RAW LacR/FMLPR.2)
that stably expressed both the human FMLP receptor and
the Lac repressor protein as a recipient cell line. This line
was used to generate further clones expressing Myc-tagged
human Rac1 N17, Cdc42 N17, and Chimaerin-GAP. Be-
tween 50 and 200 clones expressing each construct were
isolated. The clones varied in their “leakiness” (i.e., expres-
sion of the Myc epitope in the absence of the inducing
agent, IPTG) and level of inducible expression. Therefore,
we determined optimal conditions for the expression of the
constructs, and selected three to six clones that displayed a
high level of inducible expression for each construct. For
example, in the absence of IPTG, minimal expression of
the Myc epitope was detected, whereas IPTG caused a
time-dependent appearance of fusion protein expression.
The addition of zinc acetate and sodium butyrate further
enhanced protein expression (Fig. 2 
 
a
 
). Fluorescence mi-
croscopy revealed a bimodal population of cells that either
did or did not express the Myc epitope. In uninduced cells,
 
,
 
1% of the cells expressed the Myc epitope, whereas addi-
tion of IPTG, zinc, and butyrate induced expression of the
Myc epitope in 20–60% of the total cell population. Clones
were selected on the basis of demonstrating uniformly
bright fluorescence in those individual cells that stained
positive for the Myc epitope (i.e., cells within a selected
clone showed a sharp contrast between Myc expression and
a lack of expression, and the variation of intensities of Myc-
positive cells was relatively small). We quantitated expres-
Figure 1. FMLP or CSF-1 induces F-actin–rich ruffles in RAW LacR/
FMLPR.2 cells. Cells were fixed and stained with rhodamine-phalloidin
as described in Materials and Methods. (a) Unstimulated. (b) Cells incu-
bated with 100 nM FMLP for 1 min. (c) Cells incubated with 10 ng/ml
CSF-1 for 5 min. Bar 5 10 mm. (d) Inhibition of FMLP-induced ruffles
by pertussis toxin (1 ng/ml for 24 h) in RAW LacR/FMLPR.2 cells.
Solid bars, 2 pertussis toxin; striped bars, 1 pertussis toxin. 
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sion of the Myc-tagged fusion proteins on a single cell basis
by measuring the fluorescence intensities of Myc-positive
cells using microspectrofluorometry. Clones that inducibly
expressed Rac1 N17 or Cdc42 N17 showed similar levels
of expression, whereas Chimaerin-GAP consistently
showed a greater level of expression on a single cell basis (
 
P
 
,
 
0.05, when compared to any other clone; Fig. 2 
 
b
 
). In
the 40–80% of the population that did not stain positive
with mAb anti-Myc despite the presence of inducing
agents, the mean fluorescence was similar to that of unin-
duced cells. Although we cannot explain why only a pro-
portion of cells of a given clone expressed the fusion pro-
teins, the nonexpressors of a given clone provided ideal
controls to test the effects of fusion protein expression on
cytoskeletal responses.
 
Rac1 N17, Cdc42 N17, and Chimaerin-GAP Inhibit Mem-
brane Ruffling Induced by FMLP or CSF-1.
 
The morphol-
ogy of cells expressing the various Myc-tagged fusion con-
structs was dependent on the specific construct expressed
and its level of expression. Relatively high levels of expres-
sion of Rac1 N17, obtainable by the addition of zinc and
butyrate, were associated with cell rounding (for example,
see Fig. 3 
 
b
 
), whereas moderate expression of either con-
struct did not lead to an altered cell morphology (results
not shown). Expression of Cdc42 N17 did not significantly
affect the morphology of the cells (Fig. 3 
 
c
 
). Cells express-
ing Chimaerin-GAP frequently appeared more spread than
control cells (Fig. 3 
 
d
 
).
Addition of FMLP to controls (Fig. 1 
 
b
 
) or to uninduced
cell lines transfected with various Myc-tagged fusion pro-
teins led to the formation of membrane ruffles (results not
shown). Addition of IPTG to cells transfected with either
Rac1 N17, Cdc42 N17, or Chimaerin-GAP led to expres-
sion of the fusion proteins and inhibition of FMLP-induced
membrane ruffling (Figs. 3, 
 
b–f
 
, and 4 
 
a
 
). The inducing
agents had no effect on FMLP-induced membrane ruffling
in controls (results not shown).
Similar results were obtained using CSF-1 as a ruffle-induc-
ing agent. Expression of Rac1 N17, Cdc42 N17, or Chi-
maerin-GAP inhibited CSF-induced membrane ruffling by
88–96%. The inhibitory effects on membrane ruffling of
Rac1 N17 and Cdc42 N17 were apparent in terms of the
number of cells that demonstrated no ruffling response and
in the extent of ruffling in those cells that did respond to
either FMLP or CSF-1 (Fig. 4 
 
c
 
).
Figure 2. Induction of expres-
sion of Myc-tagged fusion pro-
teins in stable RAW cell trans-
fectants. (a) 106 RAW cells
(derived from a clone of RAW
LacR/FMLPR.2 cells transfected
with Myc-tagged Chimaerin-
GAP) were incubated for 0, 5, or
15 h in the presence or absence of
10 mM IPTG, 50 mM zinc, and
2 mM butyrate. Cells were sub-
jected to detergent lysis, SDS-
PAGE, and immunoblotting
with either anti-Myc or antiactin
mAbs. Lanes 1 and 4, unin-
duced; lanes 2 and 3, induced
with IPTG only; lanes 5 and 6,
induced with IPTG, butyrate,
and zinc. (b) Average levels of
expression of Myc-tagged fusion
proteins in individual cells. In-
duction of protein expression
was performed as described in
Materials and Methods and cells were fixed and stained with anti-Myc
mAb and processed for microspectrofluorometry. Expression levels are
shown in arbitrary fluorescence units. Nonspecific fluorescence (i.e., of
uninduced cells or untransfected cells) was ,10% of the total fluores-
cence signal. Data are expressed as the mean fluorescence (6 SEM) of
150–200 Myc-positive cells and represent all Myc-positive cells observed
in 5–10 high power fields from three separate experiments.
Figure 3. Expression of Myc-tagged Rac1 N17, Cdc42 N17, or Chi-
maerin-GAP inhibits ruffling in response to FMLP. Cells were incubated
with 100 nM FMLP for 1 min before fixation and staining with rho-
damine-phalloidin to detect F-actin and mAb anti-Myc followed by
FITC anti–mouse IgG to detect the indicated fusion proteins, as described
in Materials and Methods. Rhodamine-phalloidin staining of a control
cell is shown in a and of representative Myc-positive cells are shown in b–d.
A field of cells, some of which express Chimaerin-GAP, is depicted in e
(stained with anti-Myc) and f (stained with rhodamine-phalloidin). a, Con-
trol; b, Rac1 N17; c, Cdc42 N17; d–f, Chimaerin-GAP. Bar 5 10 mm.
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Rac1 N17, Cdc42 N17, and Chimaerin-GAP Inhibit Fc
 
g
 
R-
mediated Phagocytosis.
 
Fc
 
g
 
R-mediated phagocytosis re-
quires the net assembly of actin which forms the structural
scaffolding that constitutes phagocytic cups. To determine
whether Rac1 or Cdc42 were required for phagocytosis,
we performed phagocytosis assays on cell populations in-
duced with IPTG and compared ingestion of IgG-RBCs in
cells that either did or did not express the various fusion
proteins. For example, expression of Cdc42 N17 blocked
ingestion of IgG-RBCs, despite the presence of surface-
bound erythrocytes (Fig. 5). Expression of Rac1 N17, Cdc42
N17, or Chimaerin-GAP profoundly inhibited phagocyto-
sis (Fig. 6). In contrast, expression of the fusion constructs
had a modest effect on particle binding. For example, ex-
pression of Rac1 N17 led to a 27 
 
6
 
 2.7% reduction in par-
ticle binding, whereas expression of Cdc42 N17 reduced
binding by 38 
 
6 9.7%. In contrast, Chimaerin-GAP had
no effect on binding efficiency (i.e., the average number of
IgG-RBCs associated with either induced or uninduced
cells was seven). Thus, inhibition of Rac1 and Cdc42 func-
tion by either dominant-negative versions of these proteins
or by GAP expression led to a disproportionate decrease in
phagocytosis, as compared to binding, of IgG-RBCs.
To determine whether the inhibition of phagocytosis
correlated with an inhibition of the submembranous accu-
mulations of F-actin, we fixed and stained various clones of
RAW cells undergoing early stages of phagocytosis. 5 min
after the onset of phagocytosis, F-actin–rich phagocytic cups
were clearly visible in control cells (Fig. 7, a and b), con-
firming earlier data (15). Expression of Rac1 N17 or Cdc42
N17 (Fig. 7, c–f) inhibited the appearance of distinct F-actin–
rich cups, although some focal accumulations of F-actin
beneath the test particles did occur in these cells. The inhi-
bition of phagocytic cup formation by Cdc42 N17 was
usually incomplete, whereas expression of Rac1 N17 abol-
ished much of the focal appearance of F-actin beneath the
test particles (compare Fig. 7 e with c). The effects of Chi-
maerin-GAP resembled that of Cdc42 N17 (results not
shown).
Cdc42 N17, but Not Rac1 N17, Inhibits PMA-induced Ruf-
fling. The qualitatively similar effects of Cdc42 N17 and
Rac1 N17 on responses mediated by structurally distinct
ligands (i.e., FMLP, CSF-1, and IgG) raised the possibility
that expression of Rac1 N17 or Cdc42 N17 led to nonspe-
cific toxic effects on RAW cells, rendering them incapable
of responding to any F-actin–mobilizing agonist. This was
Figure 5. Inhibition of FcgR-mediated phagocytosis by Cdc42 N17.
Phagocytosis assay was performed as described in Materials and Methods.
(a) Phase-contrast micrograph. (b) Fluorescence micrograph of rhodamine
anti–rabbit IgG-stained cells to indicate presence of IgG-RBCs. After fix-
ation and permeabilization, uningested erythrocytes appear crenated. (c)
Fluorescence micrograph of anti-Myc–stained cell to indicate expression
of Myc-tagged Cdc42 N17. Note ingestion of IgG-RBCs in neighboring
cells not expressing the Myc epitope.
Figure 6. Expression of Myc-
tagged Rac1 N17, Cdc42 N17,
or Chimaerin-GAP inhibits
FcgR-mediated phagocytosis.
Striped bars, Myc-expressing cells;
solid bars, controls, which are de-
rived from the same clones but
did not express the Myc epitope
by indirect immunofluorescence.
Phagocytosis indices of cells in-
cubated in the absence of IPTG,
zinc, and butyrate were indistin-
guishable from cells that were in-
cubated with these agents but did not express Myc. Data are expressed as the
mean  6 SEM, n 5 3. The reduction of phagocytosis by Rac1 N17,
Cdc42 N17, or Chimaerin-GAP was statistically significant (P ,0.005).
Figure 4. Ruffling indices and scores of FMLP- or CSF-1–stimulated
RAW cells transfected with the indicated constructs. Narrow striped bars,
Myc-expressing cells; solid bars, controls, derived from the same clones but
which did not express the Myc epitope by indirect immunofluorescence.
Ruffling indices of cells incubated in the absence of IPTG, zinc, and bu-
tyrate were indistinguishable from cells that were incubated with these
agents but did not express Myc. a, FMLP; b, CSF-1. Data are expressed as
the mean 6 SEM, n 5 3. The reduction of ruffling by Rac1 N17, Cdc42
N17, or Chimaerin-GAP was statistically significant (P ,0.005). (c) His-
tograms of ruffling scores of individual cells stimulated with the indicated
agonist. The extent of ruffling of each cell was scored using a scale of 0–2,
where 0 indicates that no ruffles were present, 1 indicates that ruffling was
confined to one area of the cell only (,25% of cell circumference), and 2
indicates that two or more discrete areas of the cell contained ruffles. 140
cells were counted for each construct.1492 Rac, Cdc42, and Phagocytosis
of particular concern in cells expressing high levels of Rac1
N17, which caused cell rounding. We tested several other
ligands for their ability to induce cytoskeletal changes in these
cells, but could not detect morphological changes after ad-
dition of lysophosphatidic acid, bradykinin, platelet activat-
ing factor, or ATP (results not shown). However, addition
of PMA caused dramatic changes in cell shape, leading to
cell spreading and membrane ruffling (Fig. 8), both of which
were inhibited by 1 mM cytochalasin D (results not shown).
In marked contrast to the above results using FMLP, CSF-1,
or IgG-RBCs, expression of Rac1 N17 did not inhibit
PMA-induced ruffling (compare Fig. 8 b with c). However,
expression of Cdc42 N17 blocked PMA-induced ruffling
(Fig. 8 d and Fig. 9). These results indicate that expression
of Rac1 N17 did not lead to a global lack of responsiveness
in these cells. PMA-induced cellular responses are often at-
tributed to activation of one or more protein kinase C iso-
forms. We could not confirm or refute this, since addition
of 5 mM calphostin C inhibited PMA-induced membrane
ruffling, whereas other inhibitors of protein kinase C, such
as chelerythrine chloride (10 mM) and staurosporine (1 mM),
did not (results not shown).
Discussion
The data presented here demonstrate a requirement for
both Rac1 and Cdc42 in membrane ruffling mediated by
several agonists, and in phagocytosis mediated by FcgRs.
The inhibition of these responses by GTP binding–defi-
cient versions of both GTPases raises the possibility that
Rac and Cdc42 bind to an identical pool of guanine nucle-
otide exchange factors, and that expression of either N17
GTPase would necessarily lead to a functional inhibition of
both proteins. This is unlikely for the following reasons:
first, the inability of Rac1 N17 to inhibit PMA-induced
ruffling demonstrates that Rac1 N17 and Cdc42 N17 be-
have differently in these cells, and thus are unlikely to inac-
tivate the same spectrum of GEFs; and second, Cdc42 N17–
expressing cells appeared morphologically normal, unlike
those expressing high levels of Rac1 N17. This further sup-
ports the concept that Rac1 and Cdc42 have distinct cy-
toskeletal-altering functions in these cells.
The lack of inhibition of PMA-induced ruffling by Rac1
N17 contrasts with earlier data in Swiss 3T3 cells (3). A re-
port of the effects of PMA on PC12 cells indicates that
Rac1 is only partly responsible for migration mediated by
this agent (23). We cannot explain these discrepancies, ex-
cept to point out that the cellular targets of PMA are poorly
understood, and may include enzymes other than the con-
Figure 8. PMA-induced ruffling is a Rac1-independent event in RAW
cell transfectants. Cells were incubated with vehicle (a) or with 100 nM
PMA (b–d), and stained with anti-Myc mAb and rhodamine-phalloidin as
described in Materials and Methods. Rhodamine-phalloidin fluorescence
is pictured. a, control; b, control incubated with PMA; c, Rac1 N17 incu-
bated with PMA; d, Cdc42 N17 incubated with PMA. Bar 5 10 mm. Figure 7. Phagocytic cup formation is inhibited by expression of Rac1
N17 or Cdc42 N17. Cells were incubated with IgG-RBCs for 5 min at
378C before fixation. Immunofluorescence using rhodamine-phalloidin and
anti–rabbit IgG was performed as described in Materials and Methods. a,
c, and e, rhodamine-phalloidin; b, d, and f, anti–rabbit IgG. a and b: con-
trol; c and d, Cdc42 N17; e and f, Rac1 N17. Bar 5 10 mm.1493 Cox et al.
ventional isoforms of protein kinase C (24). In addition,
the effects of PMA on the cytoskeleton and the signaling
requirements that underlie these effects may be cell-type
specific.
These data question whether a true hierarchy of GTPases
exists in these cells; for example, in Swiss 3T3 cells, the ap-
pearance of Cdc42-mediated focal complexes and lamelli-
podia is blocked by coinjection of Rac1 N17, suggesting
that Rac1 lies downstream of Cdc42 in these cells (25). How-
ever, the disparate requirements for Rac1 and Cdc42 in mem-
brane ruffling stimulated by PMA in macrophages suggest
that Cdc42 does not require the participation of Rac1 to
mediate ruffling. It is possible that Cdc42 activates Rac1 in
these cells, but that activated Rac1 does not participate in
PMA-stimulated membrane ruffling.
Expression of either Rac1 N17 or Cdc42 N17 led to a
similar extent of inhibition of membrane ruffling in re-
sponse to CSF-1 or FMLP. Somewhat puzzling was the
finding that their expression did not ablate the focal appear-
ance of F-actin beneath adherent IgG-RBCs, although
both proteins blocked phagocytosis and inhibited the ap-
pearance of well-formed phagocytic cups. There are several
potential explanations for these results. One, which we fa-
vor, is that multivalent or clustered stimuli serve as particu-
larly effective ligands for receptors whose actual affinity for
univalent ligands (i.e., monomeric IgG) may be low. En-
gagement of the cytoskeletal machinery by these particulate
agonists relies on their ability to recruit signal-transducing
elements to a highly concentrated region beneath the plasma
membrane. Thus, we would predict that equivalent levels
of expression of potential inhibitory constructs may not be
as potent in inhibiting solid phase (e.g., IgG-RBCs), as op-
posed to soluble (e.g., FMLP) ligands. Incomplete efficacy
of inhibition may explain why the expression of Rac1 N17
or Cdc42 N17 did not completely abolish the focal appear-
ance of F-actin beneath the attached IgG-RBCs. Another
potential explanation is that multiple GTPases contribute to
FcgR-directed actin assembly, including additional GTPases
that have yet to be identified, and that all are required for
the coordinated extension of pseudopods and closure of
phagosomes. The comparatively less severe effects of Cdc42
N17 on FcgR-directed cytoskeletal alterations suggest that
Cdc42 may modulate the cytoarchitecture of pseudopods,
rather than actually initiate actin filament nucleation or un-
capping, although this remains to be formally tested. Other
possible explanations for the inhibitory effects of Rac1 N17
and Cdc42 N17 on cytoskeletal responses include decreased
substrate adherence or other nonspecific toxic effects. We
think these possibilities are unlikely since expression of
Cdc42 N17 did not lead to detectable changes in the cell
surface area or adhesion to the substrate. Expression of
Chimaerin-GAP, which led to similar inhibitory effects on
cytoskeletal responses, frequently led to enhanced cell spread-
ing, an effect more consistent with increased cell-substratum
attachment. Attesting to a lack of global toxicity, expres-
sion of Rac1 N17 did not affect PMA-mediated membrane
ruffling, and expression of both N17 GTPases or Chimae-
rin-GAP did not ablate some aspects of signal transduction
mediated by LPS (our manuscript in preparation), indicat-
ing that not all receptor-mediated responses are inhibited
by these constructs.
Based on the above results, we suggest that receptor-
mediated cytoskeletal events in these cells trigger activation
of multiple Rho family GTPases, and that they function in
a coordinated, but not necessarily hierarchical, manner.
This model implies that the enzymes are not interchange-
able with respect to their abilities to induce alterations in
the cytoskeleton, and it is consistent with differences in
their subcellular localization (26) and ability to interact
with distinct effectors (1). This is also supported by func-
tional differences between effector domain mutants of Rac
and Cdc42. Mutation at position 37 of Rac1 abolishes its
ability to mediate membrane ruffling and interact with Por1
(27), whereas the analogous mutation in Cdc42 does not pro-
duce this effect (28). We are currently examining the sub-
cellular localization and potential protein–protein interac-
tions of Rac1 and Cdc42 that occur during membrane ruffling
and phagocytosis in order to further address their functions.
Figure 9. Ruffling indices of
PMA-stimulated RAW cells
transfected with the indicated con-
structs. Striped bars, Myc-express-
ing cells; solid bars, controls, which
are derived from the same clones
but did not express the Myc
epitope by indirect immunofluo-
rescence. Ruffling indices of cells
incubated in the absence of
IPTG, zinc, and butyrate were
indistinguishable from cells that
were incubated with these agents
but did not express Myc. Data are expressed as the mean 6 SEM, n 5 3.
The reduction of ruffling by Cdc42 N17 or Chimaerin-GAP was statisti-
cally significant (P ,0.005).
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